Plexxikon – Scaffold-Based Drug Discovery

Plexxikon

Scaffold-Based Drug Discovery

  • Cardio-Renal
  • CNS
  • Inflammation
  • Metabolic Disease
  • Oncology
  • Cardio-Renal
  • CNS
  • Inflammation
  • Metabolic Disease
  • Oncology
  • About
    • Management
  • Pipeline
    • Cardio-Renal
    • CNS
    • Inflammation
    • Metabolic Disease
    • Oncology
  • Clinical Trials
  • Partners
  • News
    • Press Releases
    • Press Kit
  • Careers
  • Contact Us
    • Driving Directions

Plexxikon News

02/19/2012
Plexxikon Announces European Approval of Zelboraf® for the Treatment of Patients with BRAF Mutation-Positive Metastatic Melanoma
12/12/2011
Plexxikon Advances Novel Targeted Treatment of PLX3397 in Blood Cancer
11/13/2011
Plexxikon Novel Agents Aim To Address Cancer Treatment in New Ways
© Plexxikon 2010     Website design: Hane Chow Inc.